4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001814
CIK 0001369786operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:00 PM ET
Size
4.8 KB
Accession
0001562180-16-001814
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Tax Payment
Common Stock
2016-02-25$14.58/sh−335$4,884→ 39,172 total
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:00 PM ET
- Size
- 4.8 KB